Cover Story
FreeReal-world Evidence
By Matthew Bin Han Ong
Ten health care research organizations, with help from FDA and NCI, have developed a set of common definitions for real-world endpoints, including overall survival, progression-free survival, and other non-traditional endpoints.
In Brief
Clinical Roundup
Trending Stories
- As Trump’s second term nears, Republican support for NIH is at a low point
By stonewalling GOP in the House, Biden’s HHS officials eroded bipartisan support for biomedical research - As Trump’s HHS pick, RFK Jr. stands to honor or squander the Kennedy legacy in cancer
- Trump 2016: A look back at the 45th president’s impact on oncology
- What will Trump’s return to the White House mean for oncology?
“Our work just got a lot more difficult.” - Menin inhibitors emerge as new treatment for advanced AML
- Kaklamani: The San Antonio Breast Cancer Symposium will focus on deescalating treatment while maintaining outcomes